Ofer Levy

20.6k total citations · 4 hit papers
215 papers, 13.2k citations indexed

About

Ofer Levy is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ofer Levy has authored 215 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Immunology, 48 papers in Pulmonary and Respiratory Medicine and 45 papers in Epidemiology. Recurrent topics in Ofer Levy's work include Immune Response and Inflammation (84 papers), Neonatal Respiratory Health Research (46 papers) and Immune responses and vaccinations (33 papers). Ofer Levy is often cited by papers focused on Immune Response and Inflammation (84 papers), Neonatal Respiratory Health Research (46 papers) and Immune responses and vaccinations (33 papers). Ofer Levy collaborates with scholars based in United States, Australia and Italy. Ofer Levy's co-authors include David J. Dowling, Tobias R. Kollmann, Ofer Mandelboim, Hagit Achdout, Zurit Levine, Amit Novik, Amir Toporik, Liat Dassa, Hrvoje Šimić and Stipan Jonjić and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ofer Levy

208 papers receiving 12.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity

2009 2.5k citations Ofer Levy, Zurit Levine et al. Proceedings of the National Academy of Sciences profile →
Innate immunity of the newborn: basic mechanisms and clinical correlates

2007 905 citations Ofer Levy profile →
Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly

2012 418 citations Ofer Levy et al. profile →
Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny

2017 300 citations Ofer Levy et al. profile →

Peers

Countries citing papers authored by Ofer Levy

Since Specialization

Citations

This map shows the geographic impact of Ofer Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Levy more than expected).

Fields of papers citing papers by Ofer Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofer Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Levy. The network helps show where Ofer Levy may publish in the future.

Co-authorship network of co-authors of Ofer Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Ofer Levy. A scholar is included among the top collaborators of Ofer Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofer Levy. Ofer Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Product and trial design considerations on the path towards a vaccine to combat opioid overdose 2025 ·npj Vaccines ·Asimenia Angelidou, (unknown), Amy C Sherman, Cameron McLoughlin, (unknown), (unknown), Abdu Saeed, Kerry McEnaney, (unknown), (unknown), Elissa R. Weitzman, Sharon Levy, David J. Dowling, Ofer Levy	2
2	Integration of Preclinical and Clinical Vaccine Safety and Immunogenicity Testing for Development of a Pediatric HIV Vaccine to Achieve Protective HIV Immunity Prior to Adolescence 2025 ·Current HIV Research ·Genevieve G. Fouda, Anjali Singh, (unknown), Holly Janes, (unknown), Ofer Levy, Di Wu, Fei Zou, Patrick Jean‐Philippe, Kristina De Paris, Koen K. A. Van Rompay, Sallie R. Permar	0
3	Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference 2024 ·Vaccine ·Donato Amodio, Asimenia Angelidou, Nicola Cotugno, Amy C Sherman, Ofer Levy, Paolo Palma, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
4	Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70 2024 ·Science Translational Medicine ·Byron Brook, Valérie Duval, Soumik Barman, (unknown), (unknown), (unknown), (unknown), K. Wade Foster, Pallab Ghosh, (unknown), (unknown), Etsuro Nanishi, Lindsey R. Baden, Ofer Levy, Thomas C. VanCott, Romain Micol, David J. Dowling	19
5	Longitudinal plasma proteomic analysis of 1117 hospitalized patients with COVID-19 identifies features associated with severity and outcomes 2024 ·Science Advances ·Arthur Viodé, Kinga K. Smolen, Patrick van Zalm, David K. Stevenson, (unknown), Kenneth C. Parker, (unknown), Ofer Levy, Judith A. Steen, Hanno Steen	11
6	Precision Vaccinology Approaches for the Development of Adjuvanted Vaccines Targeted to Distinct Vulnerable Populations 2023 ·Pharmaceutics ·(unknown), Etsuro Nanishi, Ofer Levy, David J. Dowling	8
7	Integrative systems biology characterizes immune-mediated neurodevelopmental changes in murine Zika virus microcephaly 2023 ·iScience ·(unknown), Amanda J. Guise, Tojo Nakayama, Christoph N. Schlaffner, (unknown), Mukesh Kumar, Long Cheng, (unknown), Andrew Kodani, Simon D. van Haren, Kenneth C. Parker, Ofer Levy, Ann Durbin, Irene Bosch, Lee Gehrke, Hanno Steen, Ganeshwaran H. Mochida, Judith A. Steen	3
8	A simple, time- and cost-effective, high-throughput depletion strategy for deep plasma proteomics 2023 ·Science Advances ·Arthur Viodé, Patrick van Zalm, Kinga K. Smolen, Benoit Fatou, David K. Stevenson, (unknown), Ofer Levy, Judith A. Steen, Hanno Steen, (unknown)	48
9	Elevated third trimester corticosteroid levels are associated with fewer offspring infections 2023 ·Scientific Reports ·(unknown), Rachel S. Kelly, Su H. Chu, Priyadarshini Kachroo, (unknown), Kevin Mendez, Sofina Begum, Hans Bisgaard, Klaus Bønnelykke, Min Kim, Ofer Levy, Augusto A. Litonjua, Craig E. Wheelock, Scott T. Weiss, Bo Chawes, Jessica Lasky‐Su	1
10	Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review 2022 ·Human Vaccines & Immunotherapeutics ·Etsuro Nanishi, Ofer Levy, Al Ozonoff	24
11	Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services 2022 ·Clinical Infectious Diseases ·Karina A. Top, Robert T. Chen, Ofer Levy, Al Ozonoff, Bruce Carleton, Nigel W. Crawford, C. Buddy Creech, Sonali Kochhar, Gregory A. Poland, (unknown), Clare Cutland	12
12	Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2) 2020 ·Cancer Immunology Research ·(unknown), (unknown), Ilona Gutcher, Wolf‐Dietrich Doecke, Merlin V. Luetke-Eversloh, Sven Golfier, Helge G. Roider, Anna-Lena Frisk, John Hunter, (unknown), (unknown), Zurit Levine, Ofer Levy, (unknown), (unknown), Gady Cojocaru, Ilan Vaknin, Bertolt Kreft, (unknown)	7
13	PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function 2019 ·Cancer Immunology Research ·Sarah Whelan, Eran Ophir, Maya F. Kotturi, Ofer Levy, Sudipto Ganguly, Ling Yan Leung, Ilan Vaknin, Sandeep Kumar, (unknown), Kyle Hansen, (unknown), (unknown), Abha Soni, Janis M. Taube, Amanda N. Fader, Tian‐Li Wang, Ie‐Ming Shih, Mark A. White, Drew M. Pardoll, Spencer C. Liang	125
14	Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity 2019 ·Cancer Immunology Research ·(unknown), Xiaoyu Pan, Eran Ophir, Zoya Alteber, (unknown), Rupashree Sen, Ofer Levy, (unknown), Ilan Vaknin, (unknown), Ran Salomon, (unknown), Ada Tam, Doron Levin, (unknown), Evgeny Tatirovsky, Arthur Machlenkin, Drew M. Pardoll, Sudipto Ganguly	45
15	OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines 2019 ·Journal of Immunology Research ·Nicola Cotugno, Alessandra Ruggiero, Veronica Santilli, Emma Concetta Manno, Salvatore Rocca, Sonia Zicari, Donato Amodio, Manuela Colucci, Paolo Rossi, Ofer Levy, Federico Martinón‐Torres, Andrew J. Pollard, Paolo Palma	24
16	Vancomycin Is Protective in a Neonatal Mouse Model ofStaphylococcus epidermidis-Potentiated Hypoxic-Ischemic Brain Injury 2019 ·Antimicrobial Agents and Chemotherapy ·Jacqueline C.Y. Lai, Pernilla Svedin, C. Joakim Ek, Amin Mottahedin, Xiaoyang Wang, Ofer Levy, Andrew Currie, Tobias Strunk, Carina Mallard	16
17	Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses 2017 ·Journal of Allergy and Clinical Immunology ·David J. Dowling, Evan A. Scott, Annette Scheid, Ilana Bergelson, (unknown), Carlo Pietrasanta, Spencer E. Brightman, Guzman Sánchez‐Schmitz, Simon D. van Haren, Jana Ninković, (unknown), Cristiana Guiducci, Alexandre de Titta, Daniel K. Bonner, Sachiko Hirosue, Melody A. Swartz, Jeffrey A. Hubbell, Ofer Levy	108
18	Hepatic Legionella pneumophila Infection in an Infant With Severe Combined Immunodeficiency 2017 ·The Pediatric Infectious Disease Journal ·Rotem Lapidot, Laila Alawdah, (unknown), Vera Paulson, Ofer Levy	2
19	Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia 2002 ·Proceedings of the National Academy of Sciences ·G. Canny, Ofer Levy, Glenn T. Furuta, (unknown), Richard B. Sisson, Charles N. Serhan, Sean P. Colgan	242
20	Recent developments in soil-nailing - Design & practice 1998 ·(unknown), Ilan Juran, Ofer Levy, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact